Voltammetric analysis of entacapone, levodopa, and carbidopa in tablets: A chemometric approach
Journal of Pharmaceutical and Biomedical Analysis · 2026
DOI: 10.1016/j.jpba.2025.117275 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2026. Verfasst von Azam Safarnejad und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Institute for Advanced Studies in Basic Sciences (IASBS), Zanjan 45137-66731, Iran. Electronic address: azaqui@cid.csic.es. Hauptthemen laut MEDLINE: Carbidopa, Levodopa, Catechols, Nitriles. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Ministry of Science Research and Technology, Ankara Universitesi, Türkiye Bilimsel ve Teknolojik Araştırma Kurumu.
Abstract (Originalsprache)
The objective of the present work is to develop a voltammetric method for the determination of entacapone (ENT) in the presence of levodopa (LEV) and carbidopa (CAR) in synthetic mixtures and pharmaceutical formulations, using a multivariate approach. ENT is an inhibitor of Catechol-O-methyltransferase (COMT), used in the treatment of Parkinson's disease as an adjunct for the combination therapy with LEV and CAR. With the optimized parameters in a pH 3.0 Britton-Robinson buffer, the quantitative analyses were assessed by the root mean square error in prediction (RMSEP), as well as the root mean square error of calibration (RMSEC) and the relative error of prediction (REP). The Radial Basis Function Artificial Neural Network (RBF-ANN) and Partial Least Squares regression (PLS) were applied for the determination of ENT in the presence of LEV and CAR. In the RBF-ANN model, the REP of 0.87 and RMSEP of 2.14×10-7 are obtained for the test data when quantifying the ENT. The RBF model, as a nonlinear calibration method, was successful for predicting ENT concentration. To evaluate the validity of the recommended method, a commercial pharmaceutical tablet (Stalevo ® 200 mg) was analyzed. RBF model has the ability to overcome difficulties such as non-linearity and overlaps in the voltammograms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Institute for Advanced Studies in Basic Sciences (IASBS), Zanjan 45137-66731, Iran. Electronic address: azaqui@cid.csic.es.
- Fırat University, Faculty of Pharmacy, Department of Analytical Chemistry, Elazıg, Türkiye.
- University of Health Sciences, Gülhane Faculty of Pharmacy, Department of Analytical Chemistry, Ankara, Türkiye; Hacettepe University, Faculty of Pharmacy, Department of Analytical Chemistry, Ankara, Türkiye.
- Ankara University, Faculty of Pharmacy, Department of Analytical Chemistry, Ankara, Türkiye.
- Ankara University, Faculty of Pharmacy, Department of Analytical Chemistry, Ankara, Türkiye. Electronic address: ozkan@pharmacy.ankara.edu.tr.
Förderung
- Ministry of Science Research and Technology
- Ankara Universitesi
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu
Zitieren
APA
Safarnejad, A., Budak, F., Cetinkaya, A., Dogan-Topal, B., & Ozkan, S. A. (2026). Voltammetric analysis of entacapone, levodopa, and carbidopa in tablets: A chemometric approach. Journal of Pharmaceutical and Biomedical Analysis. https://doi.org/10.1016/j.jpba.2025.117275
Vancouver
Safarnejad A, Budak F, Cetinkaya A, Dogan-Topal B, Ozkan SA. Voltammetric analysis of entacapone, levodopa, and carbidopa in tablets: A chemometric approach. Journal of Pharmaceutical and Biomedical Analysis. 2026. doi:10.1016/j.jpba.2025.117275
BibTeX
@article{Safarnejad2026,
author = {Safarnejad, Azam and Budak, Fatma and Cetinkaya, Ahmet and Dogan-Topal, Burcu and Ozkan, Sibel A},
title = {Voltammetric analysis of entacapone, levodopa, and carbidopa in tablets: A chemometric approach},
journal = {Journal of Pharmaceutical and Biomedical Analysis},
year = {2026},
doi = {10.1016/j.jpba.2025.117275}
}
EUVIMED